This article provides an overview of the regulation of medical devices and drugs in the European Union and the US. It is important for all stakeholders involved in bringing a medical device or drugs to market to have an understanding of the regulatory requirements involved in this process. This article demonstrates that the regulation of these products is an extremely complex process.
European Commission. Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. L 169. Official Journal of the European Communities. 1993;July 12:1–43.
2.
European Commission. Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices. L 189. Official Journal of the European Communities. 1990;July 20:17–36.
3.
European Commission. Council Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. L 331. Official Journal of the European Communities. 1998;December 7:1–37.
4.
International Organization for Standardization. DIN EN ISO 14155 2012–01. Clinical investigation of medical devices for human subjects: good clinical practice.
5.
FDA. Title 21, parts 800-1299. In: Code of Federal Regulations. Washington, DC: US Department of Health and Human Services; 2002.
6.
FDA. Federal Food, Drug, and Cosmetic Act: 21 CFR 3.2(e). In: Code of Federal Regulations. Washington, DC: US Department of Health and Human Services; 2006.
7.
MaiselWH. Medical device regulation: an introduction for the practicing physician. Ann Intern Med. 2004;140(4):296–302.
8.
Federal Drug Administration Modernization Act. Public Law. 1997;105–115.
9.
European Commission. Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary drugs L 22. Official Journal of the European Communities. 1965; January 26: 669–373.
10.
European Commission. Council Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to drugs for human use (text with EEA relevance). L.136. Official Journal of the European Communities. 2004. March 31:34–57.
11.
RagoLSantosoB.Drug regulation: history, present and future. In: van BoxtelCJSantosoBEdwardsIR eds. Drug Benefits and Risks: International Textbook of Clinical Pharmacology (2nd ed rev). IOS Press and Uppsala Monitoring Centre; 2008. 65–76.
GrignoloA. Collaboration and convergence bringing new medicines to global markets in the 21st century. Therapeutic Innovation & Regulatory Science. 2013;47(1):8–15.
15.
HamrellMR. An overview of the US regulatory environment for drug-device and biologic-device combination products. Drug Inf J. 2006;40(1):23–32.
